Phase 1 Study of CH505 HIV Vaccine Nanoparticles and mRNA Boosters in Healthy Adults
Phase 1 Study of CH505 HIV Vaccine Nanoparticles and mRNA Boosters in Healthy Adults
Recruiting · NCT07757802 · Registry updated 2026-10-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase 1 Study of CH505 HIV Vaccine Nanoparticles and mRNA Boosters in Healthy Adults | HIV | Recruiting | Phase 1 | 2026-10-09 | NCT07757802 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | 402 |
8 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| BIDMC VCRS Site# 32077 | Boston | United States | 1 |
| Bridge HIV CRS Site# 30305 | San Francisco | United States | 1 |
| Brigham and Women's Hospital Vaccine CRS (BWH VCRS) Site# 30007 | Boston | United States | 1 |
| Penn Prevention CRS Site# 30310 | Philadelphia | United States | 1 |
| The Ponce de Leon Center CRS Site# 5802 | Atlanta | United States | 1 |
| University of Pittsburgh CRS Site# 1001 | Pittsburgh | United States | 1 |
| University of Rochester Vaccines to Prevent HIV Infection CRS Site# 31467 | Rochester | United States | 1 |
| Vanderbilt Vaccine (VV) CRS Site# 30352 | Nashville | United States | 1 |